PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical

The Pharma Industry should act now to avoid Brexit-related Production and Warehousing woes

Brexit-related stockpiling is driving up the cost of space available at pharmaceutical production sites, factories, and warehouses across the UK – as businesses guard against the prospect of a no-deal outcome. Leading solutions provider, Dawsongroup TCS, is urging the industry to take action now and look to “usership” rather than “ownership” to meet demand and prepare for change.Rod Benham, Managing Director of Dawsongroup TCS, said: “Significant political uncertainty means the wider pharmaceutical industry faces even more ambiguity, despite the clock continuing to tick ahead of the UK’s scheduled departure from the European Union.

“When it comes to precautionary stockpiling, a lack of space, the need to meet demand quickly, and uncertainty around the long-term business requirements, are posing large and problematic constraints on the industry.”With temperature-controlled warehouses in desperately short supply in the UK, it may not even be possible for businesses to find the space required. Furthermore, it’s often not suitable for businesses to invest in building concrete, permanent extensions due to invariable market confidence and uncertainty.

Rod continues: “Rental is the way forward for key players in pharmaceuticals if they want to stockpile and be ready for any Brexit-related market changes without the need for capital funding – and there are plenty of options to consider. Portable coldstores come without any feasibility costs and if space is an issue, tailored buildings can also be specifically designed. Inflatable coldstores can be transported on a single pallet and installed in just 90 minutes, minimising disruption to businesses. They can also be sited on almost any hard-standing surface and are rigid enough to withstand extreme weather.”Most importantly, rental can allow a solution to be supplied in weeks, as opposed to months, or even years. This is great if, for example, a business has secured a new contract or does need to stockpile, meaning a quick factory extension is necessary in order to meet rising production demands.

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026